Gene activation by a CRISPR-assisted enhancer.

Elife

State Key Laboratory of Bioelectronics, Southeast University, Nanjing, China.

Published: April 2019

AI Article Synopsis

  • Researchers created a new technique, called CRISPR-assisted enhancer, to improve the efficiency of gene activation using the deactivated CRISPR/Cas9 system (dCas9).
  • This method combines dCas9 with a powerful CMV enhancer and uses two different systems to recruit the enhancer to target genes.
  • The new approach significantly boosts gene expression compared to traditional dCas9 activators, working effectively on both introduced reporter genes and natural genes in various cell types.

Article Abstract

The deactivated CRISPR/Cas9 (dCas9) is now the most widely used gene activator. However, current dCas9-based gene activators are still limited by their unsatisfactory activity. In this study, we developed a new strategy, the CRISPR-assisted enhancer, for activating gene expression at high efficiency by combining dCas9-VP64/sgRNA with the widely used strong CMV enhancer. In this strategy, CMV enhancer DNA was recruited to target genes in by two systems: dCas9-VP64/csgRNA-sCMV and dCas9-VP64-GAL4/sgRNA-UAS-CMV. The former recruited enhancer by annealing between two short complementary oligonucleotides at the ends of the sgRNA and enhancer. The latter recruited enhancer by binding between GAL4 fused to dCas9 and UAS sequence of enhancer. The enhancer activated gene transcription as the natural looped enhancer. The enhancer could activate both exogenous reporter genes and variant endogenous genes in various cells, with much higher activation efficiency than that of current dCas9 activators.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478495PMC
http://dx.doi.org/10.7554/eLife.45973DOI Listing

Publication Analysis

Top Keywords

enhancer
11
crispr-assisted enhancer
8
cmv enhancer
8
recruited enhancer
8
enhancer enhancer
8
gene
5
gene activation
4
activation crispr-assisted
4
enhancer deactivated
4
deactivated crispr/cas9
4

Similar Publications

Background: Adenoid cystic carcinoma of the breast is a rare subtype, constituting less than 3.5% of primary breast carcinomas. Despite being categorized as a type of triple-negative breast cancer, it generally has a favorable prognosis.

View Article and Find Full Text PDF

The therapeutic role of naringenin nanoparticles on hepatocellular carcinoma.

BMC Pharmacol Toxicol

January 2025

Biochemistry Department, Faculty of Science, Tanta University, Tanta, Egypt.

Background: Naringenin, a flavonoid compound found in citrus fruits, possesses valuable anticancer properties. However, its potential application in cancer treatment is limited by poor bioavailability and pharmacokinetics at tumor sites. To address this, Naringenin nanoparticles (NARNPs) were prepared using the emulsion diffusion technique and their anticancer effects were investigated in HepG2 cells.

View Article and Find Full Text PDF

Background: The evidence indicates that functional training is beneficial for athletes' physical and technical performance. However, a systematic review of the effects of functional training on athletes' physical and technical performance is lacking. Therefore, this study uses a literature synthesis approach to evaluate the impact of functional training on the physical and technical performance of the athletic population and to extend and deepen the existing body of knowledge.

View Article and Find Full Text PDF

Background: To identify the relationship between BMI or lipid metabolism and diabetic neuropathy using a Mendelian randomization (MR) study.

Methods: Body constitution-related phenotypes, namely BMI (kg/m), total cholesterol (TC), and triglyceride (TG), were investigated in this study. Despite the disparate origins of these data, all were accessible through the IEU OPEN GWAS database ( https://gwas.

View Article and Find Full Text PDF

Purpose: This scoping review aims to summarize online health information seeking (OHIS) behavior among breast cancer patients and survivors, identify research gaps, and offer insights for future studies.

Methods: Following Arksey and O'Malley's framework, we conducted a review across PubMed, Web of Science, CINAHL, MEDLINE, Cochrane, Embase, CNKI, Wanfang Data, and SinoMed, covering literature from 1 January 2014 to 13 August 2023. A total of 1,368 articles were identified, with 33 meeting the inclusion criteria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!